Catalano, M. Et Al. 2008. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease. Clinical Biochemistry , vol.41 , 981-985.

Catalano, M., Cortelazzo, A., Santi, R., Contino, L., Demicheli, M., Yilmaz, Y., ... Zorzetto, M.(2008). The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease. Clinical Biochemistry , vol.41, 981-985.

Catalano, Mariella Et Al. "The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease," Clinical Biochemistry , vol.41, 981-985, 2008

Catalano, Mariella Et Al. "The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease." Clinical Biochemistry , vol.41, pp.981-985, 2008

Catalano, M. Et Al. (2008) . "The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease." Clinical Biochemistry , vol.41, pp.981-985.

@article{article, author={Mariella Catalano Et Al. }, title={The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease}, journal={Clinical Biochemistry}, year=2008, pages={981-985} }